Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Correlations Between Oxidative Stress Biomarkers, h-FABP and Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Undergoing Primary PCI

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеНабиране
Спонсори
Grigore T. Popa University of Medicine and Pharmacy
Сътрудници
Cardiovascular Diseases Institute IASI, Romania

Ключови думи

Резюме

The investigators intend to evaluate Oxidative Stress biomarkers through a. Catalase Activity Assay; b. Lipid Peroxidation Assay; c. SOD Assay; d. Total Antioxidant Capacity Assay; e. Glutathione Peroxidase at patients with acute myocardial infarction STEMI referred for primary PCI; The investigators also aim to evaluate cardiac necrosis by measuring Heart Fatty Acid Binding Protein (H-FABP), TnI, CK, CK-MB, LDH and AST in these patients with acute myocardial infarction referred for primary PCI; Also, the investigators intend to evaluate body composition through bioimpedance spectroscopy (BCM - Fresenius Care) at the moment of admission.
The investigators aim to fully characterise these patients through oxidative millieu, hFABP and make correlations with LVEF dysfunction.

Описание

Gathered data:

- Descriptive general demographic data;

- Previous pathologies (ischemic heart disease, peripheral arterial disease, stroke, heart failure, previous percutaneous coronary interventions, coronary artery bypass grafting - CABG, known renal disease);

- Cardiovascular risk factors (age, weight, height, abdominal perimeter, body mass index, smoking, sedentariness, diabetes, hypertension, dyslipidaemia);

- Oxidative Stress biomarkers: Catalase Activity Assay; Lipid Peroxidation Assay; SOD Assay; Total Antioxidant Capacity Assay; Glutathione ;

- Cardiac necrosis markers: Heart Fatty Acid Binding Protein (H-FABP), TnI, CK, CK-MB, LDH and OGT;

- Routine biological data;

- Metabolic data (obtained from two body composition monitoring evaluations - before and 12 hours after coronary intervention) - body water, body fat tissue;

- Information regarding primary PCI (less than 12 hours of ischemic symptoms);

- Coronarographic details, type of used stent, periprocedural specific complications, final TIMI - thrombolysis in myocardial infarction - flow);

- Echocardiography at admission (LVEF);

- Measurement of arterial stiffness through Sphigmocore pulsed-wave-velocity (24 hrs post-procedural, 2 velocities: carotid - femoral and carotid - radial);

- Calculating of cardiovascular risk scores: Syntax Score, Framingham score, ASSIGN score, QRISK2 score, PROCAM score, CRUSADE score, GRACE score, CHADS VASc score, MESA score, ASCVD score, Hamilton Depression Rating Scale (HAM-D), Hamilton Rating Scale for Anxiety;

- In-hospital and one month follow-up MACE.

Дати

Последна проверка: 06/30/2019
Първо изпратено: 07/23/2019
Очаквано записване подадено: 07/23/2019
Първо публикувано: 07/28/2019
Изпратена последна актуализация: 07/26/2019
Последна актуализация публикувана: 07/29/2019
Действителна начална дата на проучването: 07/31/2019
Приблизителна дата на първично завършване: 06/30/2020
Очаквана дата на завършване на проучването: 07/31/2020

Състояние или заболяване

STEMI
Oxidative Stress
Oxidative Stress Induction
Primary PCI
hFABP
Left Ventricular Dysfunction
BCM

Интервенция / лечение

Other: primary PCI STEMI patients

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Other: primary PCI STEMI patients
All Patients with AMI refered for primary PCI in single center
Other: primary PCI STEMI patients
Dosing oxidative stress biomarkers and hFABP in STEMI pPCI

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 18 Years Да се 18 Years
Полове, допустими за проучванеAll
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

- Adults with ST elevation Myocardial Infarction (<12h) diagnostic confirmed;

- Included in the Romanian National Programme of Primary Percutaneous Revascularisation (for who the Guidelines recommend primary PCI);

Exclusion Criteria:

- Patients who do not sign informed consent for primary PCI

Резултат

Първични изходни мерки

1. Oxidative Stress status in Acute Myocardial Infarction Patients undergoing primary PCI [1 year]

Assessment of oxidative stress status by measuring Catalase Activity Assay; Lipid Peroxidation Assay; SOD Assay; Total Antioxidant Capacity Assay; Glutathione Peroxidase.

2. 2. Cardiac necrosis status in Acute Myocardial Infarction Patients undergoing primary PCI. [1 year]

Assessment of cardiac necrosis by measuring Heart Fatty Acid Binding Protein (H-FABP), TnI, CK, CK-MB, LDH and AST

Вторични изходни мерки

1. Hydation Status in Acute Myocardial Infarction Patients undergoing primary PCI. [1 year]

Assessment of hydration status through body composition monitoring BCM.

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge